Cannabis company Cresco Labs generated $26 million in cash from operations, but lost $15 million.
Cresco Labs reported Q3 2026 revenue of $173 million, a gross profit of $79 million, and a net loss of $15 million. The company generated $26 million in operating cash flow. Management highlighted preparedness for federal regulatory changes. As of September 30, 2026, Cresco Labs had $454 million in cash and $76 million in long-term debt.
How this was made
The 30-second read
Why it matters
The earnings release provides the first public view of Q3 performance, setting expectations for FY guidance and future cash generation.
Market read
Quarterly earnings are a primary catalyst for the stock and may influence sector sentiment.
What to watch
Potential impact of upcoming federal reforms and upcoming shareholder resolutions.
Background
Cresco Labs is a leading U.S. cannabis cultivator and brand operator; the company recently secured shareholder approval for three special resolutions.
Market effects
Shows cash‑flow challenges in the cannabis sector, may affect peer valuations.
U.S. cannabis stocks could see broader re‑rating based on Cresco's results.
Limited to cannabis industry participants.
Counterpoint
Despite the loss, strong cash flow could support a buy‑the‑dip stance.
Key entities
- companyCresco Labs Inc.
U.S. cannabis producer and brand owner.
